Palvella Therapeutics receives Yale-licensed patent for QTORIN pitavastatin

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Palvella Therapeutics receives Yale-licensed patent for QTORIN pitavastatin
(NASDAQ: PVLA) Delayed: 108.81 +2.43 (2.28%)
Previous Close $106.38    52 Week High $ 
Open $106.82    52 Week Low $ 
Day High $109.01    P/E N/A 
Day Low $104.77    EPS $ 
Volume 360,812